 |
|
Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs
Jung Gi Rho, Change Dae Kum, Young Jun Seo, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
Ann Pediatr Endocrinol Metab. 2021;26(4):266-271. Published online 2021 May 20 DOI: https://doi.org/10.6065/apem.2040286.143
|
|
Citations to this article as recorded by
 Comprehensive analysis of chemokine gene polymorphisms in Korean children with autoimmune thyroid disease
Chungwoo Shin, In-Cheol Baek, Won Kyoung Cho, Tai-Gyu Kim, Byung-Kyu Suh
Scientific Reports.2023;[Epub] CrossRef Updates in the Management of Graves Disease in Children
Yun Jeong Lee
The Ewha Medical Journal.2023;[Epub] CrossRef Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”
Ji Hyun Kim
Annals of Pediatric Endocrinology & Metabolism.2022; 27(4): 245. CrossRef
|